ESC Professional Premium Access

Primary care and noncardiac surgery / Presurgical assessment

Event: ESC Congress 2022
Topic: Cardiovascular Disease in Special Populations
Session type: Moderated ePosters
Date: 26 August 2022
Time: 10:15 - 11:00

Congress Session

6 presentations in this session

Long term outcomes in different aetiologies of perioperative myocardial infarction/injury after noncardiac surgery

Speaker: Doctor C. Puelacher (Basel, CH)
Thumbnail

Risk stratification of perioperative myocardial infarction/injury following noncardiac surgery in high risk patients

Speaker: Doctor C. Puelacher (Basel, CH)
Thumbnail

Evaluation of the Marburg Heart Score and INTERCHEST score compared to current telephone triage for chest pain in out-of-hours primary care

Speaker: Doctor R. Harskamp (Amsterdam, NL)
Thumbnail

Impact of the implementation of electronic consultation in outpatient care for patients with cardiovascular disease in a Cardiology Service of a tertiary hospital

Speaker: Doctor P. Mazon Ramos (Santiago de Compostela, ES)
Thumbnail

Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes

Speaker: Doctor D. Gualandro (Basel, CH)
Thumbnail

Performance of Society of Thoracic Surgeons and EuroSCORE II pre-surgical mortality risk score for cardiac surgery in a large majority-minority population

Speaker: Mr B. Seto (Honolulu, US)
Thumbnail

6 speakers from this session

Doctor Christian Puelacher

University Hospital Basel, Basel (Switzerland)
3 presentations
0 follower

Doctor Christian Puelacher

University Hospital Basel, Basel (Switzerland)
3 presentations
0 follower

Doctor Ralf Harskamp

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
1 presentation
0 follower

Doctor Pilar Mazon Ramos

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
0 follower

Doctor Danielle Gualandro

University Hospital Basel, Basel (Switzerland)
3 presentations
1 follower

Mr Brendan Seto

, Honolulu (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk